GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arno Therapeutics Inc (OTCPK:ARNI) » Definitions » 50-Day SMA

Arno Therapeutics (Arno Therapeutics) 50-Day SMA : $0.00 (As of May. 06, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Arno Therapeutics 50-Day SMA?

Moving averages are one of the core indicators in technical analysis. A Simple Moving Average (SMA) is simply the arithmetic average of stock price over a period. It is calculated by adding a selected range of prices, usually closing prices, and then dividing that figure by the number of time periods in that range.

The 50-Day SMA calculates the average price over 50 days. And the 20-Day SMA and 200-Day SMA calculates the average price over 20 days and 200 days separately.

As of today (2024-05-06), Arno Therapeutics's 50-Day SMA is $0.00. It's 20-Day SMA is $0.00 and 200-Day SMA is $0.00.


Competitive Comparison of Arno Therapeutics's 50-Day SMA

For the Biotechnology subindustry, Arno Therapeutics's 50-Day SMA, along with its competitors' market caps and 50-Day SMA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arno Therapeutics's 50-Day SMA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arno Therapeutics's 50-Day SMA distribution charts can be found below:

* The bar in red indicates where Arno Therapeutics's 50-Day SMA falls into.



Arno Therapeutics  (OTCPK:ARNI) 50-Day SMA Calculation

The formula for calculating SMA is:

SMA=( P1 + P2 + ... + Pn ) / n

where:
Pn is the price of the stock at period n.
n is the total number of periods.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arno Therapeutics  (OTCPK:ARNI) 50-Day SMA Explanation

Simple Moving Average (SMA) is the arithmetic average of stock price over a period. The 20-Day SMA calculates the average price over 20 days. And the 50-Day SMA and 200-Day SMA calculates the average price over 50 days and 200 days separately. SMAs are often used to determine the price trend direction. A 200-Day SMA is usually a proxy for the long-term trend, while shorter periods indicate short-term trend.

SMA are commonly compared with stock price or different period SMAs to indicate a trading signal. Generally speaking, if the price goes above the SMA, or a short-term SMA crosses above a long-term SMA, an uptrend is expected, investors may want to go long or cover short. Conversely, if the price goes below the SMA, or the short-term SMA crosses below a long-term SMA, a downtrend is expected, investors may want to go short or exit long.

Two popular trading patterns that use SMA include the death cross and a golden cross. A death cross occurs when the 50-day SMA crosses below the 200-day SMA. This is considered a bearish signal, that further losses are in store. The golden cross is a bullish signal which occurs when a short-term SMA crosses above a long-term SMA.


Arno Therapeutics 50-Day SMA Related Terms

Thank you for viewing the detailed overview of Arno Therapeutics's 50-Day SMA provided by GuruFocus.com. Please click on the following links to see related term pages.


Arno Therapeutics (Arno Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
200 Route 31 North, Suite 104, Flemington, NJ, USA, 08822
Arno Therapeutics Inc operates as a biopharmaceutical company. It develops drug candidates to treat patients with cancer and other life-threatening diseases. It develops pre-clinical and clinical-stage product under the following name: Onapristone, AR-42, and AR-12. Onapristone is indicated for endometrial, prostate and breast cancer indications, AR-42 is provided for hematological malignancies and solid tumors indications and AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets.
Executives
S Donald Sussman other: See Footnote 1 888 EAST LAS OLAS BLVD, SUITE 710, FORT LAUDERDALE FL 33301
David M Tanen director, officer: Secretary TWO RIVER GROUP HOLDINGS, LLC., 689 FIFTH AVENUE, NEW YORK NY 10022
Tomer Kariv director C/O ARNO THERAPEUTICS, INC., 200 ROUTE 31 NORTH, SUITE 104, FLEMINGTON NJ 08822
Arie Belldegrun director UCLA SCHOOL OF MEDICINE, 10833 LE CONTE 66-118 CHS BOX 951738, LOS ANGELES CA 9095-1738
Alexander A Zukiwski director, officer: Chief Executive Officer & CMO 200 ROUTE 31 NORTH, SUITE 104, FLEMINGTON NJ 08822
Jay Moorin director C/O PROQUEST INVESTMENTS, L.P, 2430 VANDERBILT BEACH ROAD, #108 - 190, NAPLES FL 34109
Lawrence A Kenyon officer: Chief Financial Officer C/O OUTLOOK THERAPEUTICS, INC., 7 CLARKE DRIVE, CRANBURY NJ 08512
Glenn R. Mattes director, officer: President & CEO 200 ROUTE 31 NORTH, SUITE 104, FLEMINGTON NJ 08822
Randy H Thurman director 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Wexford Gp Llc other: No longer own 10% of Issuer C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH CT 33401
Joseph Jacobs other: No longer own 10% of Issuer C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602 EAST, WEST PALM BEACH FL 33401
Wexford Capital Lp other: No longer own 10% of Issuer 777 WEST PUTNAM AVENUE, 1ST FLOOR, GREENWICH CT 06830
Charles E Davidson other: No longer own 10% of Issuer C/O WEXFORD CAPITAL LP, 777 SOUTH FLAGLER DRIVE, SUITE 602, WEST PALM BEACH FL 33401
Ran Nussbaum 10 percent owner C/O KITE PHARMA, INC., 2225 COLORADO AVENUE, SANTA MONICA CA 90404
Brian Lenz officer: Chief Financial Officer 65 COMMERCE WAY, HACKENSACK NJ 07601

Arno Therapeutics (Arno Therapeutics) Headlines

No Headlines